Asia: a cut above other emerging markets

Asia has grown at about 7% annually, accounting for over half the world's growth as Asian consumers have begun spending - and this story is far from over.

"If I am going to take a long-term view", I would much prefer to invest in Asia than in Europe or the US, says David Fuller on Fullermoney.com. You can see why. Over the past few years, Asia has grown at about 7% annually, accounting for over half the world's growth as Asian consumers have begun spending and this story is far from over.

In China, for instance, retail sales have jumped by almost 50% over the past four years, but with more than 80% of Chinese buyers making their first car purchase, there is vast scope for further growth as the country industrialises. And Asia's yield appeal has improved markedly of late. Firms have paid down debt and boosted profitability and cash flows, which has allowed them to grow dividends; Mike Kerley of Henderson Global Investors notes that "Asian markets now offer an income premium over those of Europe and the US".

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.